Mortality Rate for Acute Mesenteric Stenosis

Epidemiology and Mortality Data

• The mortality rate for acute mesenteric ischemia (AMI) remains extremely high at 50-80% if untreated, despite advances in diagnostic and treatment modalities 1, 2
• AMI is an uncommon condition with an incidence of 0.09-0.2% of all acute surgical admissions, but its prevalence increases with age 1, 3
• Mortality rates consistently exceed 50% in most studies, with some reporting rates as high as 70-100% in specific high-risk populations 2

Factors Affecting Mortality

• Time to diagnosis and intervention is critical: Delayed diagnosis significantly increases mortality 1, 4
• Etiology of ischemia impacts survival rates: Arterial embolism (50% of cases) has a generally better prognosis if treated early, while non-occlusive mesenteric ischemia (NOMI) has high mortality due to difficult diagnosis 4, 5, 6
• Extent of intestinal necrosis: Presence of bowel infarction dramatically increases mortality 6

Treatment Approaches and Impact on Mortality

• Endovascular approaches have shown improved outcomes compared to traditional open surgery, with lower rates of mortality, decreased amount of bowel resection, and lower incidence of renal and respiratory failure 4, 6
• Clinical pathways and specialized centers of excellence have demonstrated reduced mortality through higher awareness of AMI, more appropriate imaging, fewer delays in treatment, and increased number of revascularizations 4, 5

Diagnostic and Treatment Pitfalls

• Delayed diagnosis is the most significant contributor to high mortality 1, 3
• Symptoms may be nonspecific, making early diagnosis challenging, and laboratory findings are often of limited value in early disease 7
• Radiographic findings typically appear late, when bowel infarction has already occurred, and failure to consider endovascular approaches when appropriate may result in unnecessary bowel resection 4, 7